IDEXX Laboratories Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 IDEXX Laboratories Inc 公司

IDEXX Laboratories, Inc. 开发、生产和分销产品，并主要为伴侣动物兽医、牲畜和家禽、乳制品和水检测行业提供服务。该公司还提供人类医疗即时诊断和实验室诊断。其部门包括伴侣动物组 (CAG)、水质产品 (水) 以及牲畜、家禽和乳制品 (LPD)。CAG 部门为伴侣动物兽医行业提供基于诊断和信息管理的产品和服务，包括临床诊断解决方案、外部参考实验室服务以及兽医软件和服务。其水部门提供测试解决方案，用于准确检测和量化水中的各种微生物参数。其 LPD 部门提供诊断测试、服务和相关仪器，用于管理牲畜和家禽的健康状况，以提高牛奶的质量和安全性。

公司简介

公司代码IDXX

公司名称IDEXX Laboratories Inc

上市日期Jun 21, 1991

成立日期1983

CEOMr. Andrew Emerson

员工数量11000

证券类型Ordinary Share

年结日Jun 21

公司地址One Idexx Drive

城市WESTBROOK

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编04092-2041

电话12075560300

网址https://www.idexx.com/

公司代码IDXX

上市日期Jun 21, 1991

成立日期1983

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Brian P. Mckeon

Chief Financial Officer, Executive Vice President, Treasurer

29.92K

+0.16%

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.43K

--

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

7.88K

--

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

+0.61%

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

5.93K

+8.90%

Mr. Daniel M. (Dan) Junius

Independent Director

2.74K

+7.24%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

2.40K

--

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

名称

名称/职务

职务

持股

持股变动

Mr. Brian P. Mckeon

Chief Financial Officer, Executive Vice President, Treasurer

29.92K

+0.16%

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.43K

--

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

7.88K

--

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

+0.61%

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

5.93K

+8.90%

收入明细

单位: USD更新时间: 4月6日周日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

CAG Diagnostics recurring revenue

3.13B

80.29%

Reference laboratory diagnostic and consulting services

1.34B

34.28%

IDEXX VetLab consumables

1.30B

33.44%

Rapid assay products

359.75M

9.23%

CAG Diagnostics capital - instruments

312.62M

8.02%

Other

-2.54B

-65.27%

地区USD

名称

营收

占比

United States

2.53B

64.99%

Other Euorpe

196.31M

5.04%

Germany

173.68M

4.46%

Canada

152.88M

3.92%

United Kingdom

134.63M

3.45%

Other

706.82M

18.14%

业务

地区

业务USD

名称

营收

占比

CAG Diagnostics recurring revenue

3.13B

80.29%

Reference laboratory diagnostic and consulting services

1.34B

34.28%

IDEXX VetLab consumables

1.30B

33.44%

Rapid assay products

359.75M

9.23%

CAG Diagnostics capital - instruments

312.62M

8.02%

Other

-2.54B

-65.27%

股东统计

更新时间: 2月21日周五

持股股东

股东类型

持股股东

股东统计

占比

The Vanguard Group, Inc.

11.94%

BlackRock Institutional Trust Company, N.A.

6.57%

State Street Global Advisors (US)

4.49%

Fundsmith LLP

3.29%

Geode Capital Management, L.L.C.

2.83%

Other

70.88%

持股股东

股东统计

占比

The Vanguard Group, Inc.

11.94%

BlackRock Institutional Trust Company, N.A.

6.57%

State Street Global Advisors (US)

4.49%

Fundsmith LLP

3.29%

Geode Capital Management, L.L.C.

2.83%

Other

70.88%

股东类型

股东统计

占比

Investment Advisor

41.57%

Investment Advisor/Hedge Fund

40.96%

Research Firm

3.74%

Pension Fund

2.27%

Hedge Fund

2.19%

Bank and Trust

1.79%

Sovereign Wealth Fund

1.34%

Individual Investor

0.67%

Family Office

0.46%

Other

5.00%

机构持股

更新时间: 1月19日周日

报告期

机构数

持股数

持股占比

持股变动

2025Q1

2216

76.97M

94.97%

-4.38M

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

2023Q1

2158

77.14M

92.96%

-2.07M

2022Q4

2124

77.44M

93.49%

-2.66M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

9.67M

11.94%

-29.32K

-0.30%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

5.32M

6.57%

-239.97K

-4.31%

Dec 31, 2024

State Street Global Advisors (US)

3.64M

4.49%

+24.20K

+0.67%

Dec 31, 2024

Fundsmith LLP

2.66M

3.29%

-1.31K

-0.05%

Dec 31, 2024

Geode Capital Management, L.L.C.

2.30M

2.83%

+37.73K

+1.67%

Dec 31, 2024

Baron Capital Management, Inc.

2.01M

2.47%

+82.26K

+4.28%

Dec 31, 2024

Invesco Capital Management (QQQ Trust)

1.69M

2.09%

+22.74K

+1.36%

Feb 28, 2025

AllianceBernstein L.P.

1.24M

1.53%

-1.58M

-56.02%

Dec 31, 2024

BlackRock Asset Management Ireland Limited

1.13M

1.39%

+36.40K

+3.33%

Dec 31, 2024

Principal Global Investors (Equity)

711.20K

0.88%

-19.27K

-2.64%

Dec 31, 2024

持股ETF

更新时间: 4月6日周日

机构名称

占比

ProShares Pet Care ETF

9.82%

iShares U.S. Medical Devices ETF

3.79%

First Trust Water ETF

3.75%

Acquirers Fund

3.67%

Inspire Tactical Balanced ETF

2.66%

First Trust S&P 500 Economic Moat Index ETF

1.99%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

1.81%

American Century Mid Cap Growth Impact ETF

1.79%

Tema Monopolies and Oligopolies ETF

1.64%

Invesco S&P 500 Equal Weight Health Care ETF

1.58%

ProShares Pet Care ETF

占比9.82%

iShares U.S. Medical Devices ETF

占比3.79%

First Trust Water ETF

占比3.75%

Acquirers Fund

占比3.67%

Inspire Tactical Balanced ETF

占比2.66%

First Trust S&P 500 Economic Moat Index ETF

占比1.99%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

占比1.81%

American Century Mid Cap Growth Impact ETF

占比1.79%

Tema Monopolies and Oligopolies ETF

占比1.64%

Invesco S&P 500 Equal Weight Health Care ETF

占比1.58%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

IDEXX Laboratories Inc

472.450USD

IDEXX Laboratories Inc

472.450

概览

公司